Search for: "Wright v. United States" Results 521 - 540 of 1,068
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Oct 2019, 4:23 pm by INFORRM
  The trial is listed for 3 days On 11 November 2019 there will be a trial in the case of Turley v Unite the Union The claimant is the MP for Redcar. [read post]
25 Apr 2014, 8:17 am by Joshua L. Firth
  Since its release in 1999, Actos has generated more than $16 billion in sales for Lilly and Takeda, who partnered together to produce and market the drug in the United States. [read post]
25 Apr 2014, 8:17 am by Joshua L. Firth
  Since its release in 1999, Actos has generated more than $16 billion in sales for Lilly and Takeda, who partnered together to produce and market the drug in the United States. [read post]
1 Jun 2022, 12:08 pm by Holly Brezee
The company may employ a third-party valuation expert to ensure that the fair market value is accurately determined and to take advantage of the safe harbor offered under Section 409A of the Internal Revenue Code of the United States (the “Code”). [read post]
30 Nov 2011, 1:59 am
 Same with Austin "Jack" DeCoster of Wright County Egg, which was linked to as many as 1,700 illnesses from Salmonella in its eggs in 2010. [read post]
6 Oct 2019, 9:53 am by Samuel Bray
Barnette, No. 591, Supreme Court of the United States, October Term, 1942, at 46. [read post]
26 May 2012, 3:02 pm by legalinformatics
Georgia Shelby Bell, University of Minnesota: The Presidency as a Tool for Foreign Policy: An Exploration of the Implications of United States v. [read post]
26 May 2012, 3:02 pm by legalinformatics
Georgia Shelby Bell, University of Minnesota: The Presidency as a Tool for Foreign Policy: An Exploration of the Implications of United States v. [read post]
17 Jun 2022, 2:09 pm by admin
  Ever since the United States Supreme Court decided Daubert v. [read post]
13 Jul 2021, 10:58 am by Simon Lester
In the United States (US), as for most developed countries,[6] trade policy and IP standards have consistently been linked, a pattern which can (at least partially) be traced back to extensive lobbying by senior management at US-based technology and pharmaceutical firms.[7] For example, since at least the 1980s, Pfizer Inc. has been involved in mobilizing other US firms and stakeholders to lobby US policymakers on the issue of international IP protection. [read post]